Patient guide
Maternal-Effect Genes: The Pregnancy-Loss Genes a Karyotype Can't See
Reticular Team
Patient Education
When people ask "what genes are linked to recurrent pregnancy loss and embryo arrest," the answer that keeps coming up is a small family of genes with an unusual property: they do their most important work in the egg, before the embryo's own DNA is even switched on. They are called maternal-effect genes, and they sit in a blind spot that chromosome tests and standard carrier screening were never designed to cover.
This is a map, not a diagnosis. These genes are rare causes, and most pregnancy loss has nothing to do with them. But for people facing repeated, unexplained failure at the earliest steps, they are the layer worth understanding.
The short answer
Maternal-effect genes control the first few days of development using supplies the egg loads in advance. Key examples tied to infertility and pregnancy loss include TUBB8 (the egg's spindle), NLRP7 (recurrent molar pregnancy), and PADI6, NLRP5, TLE6, KHDC3L and OOEP (the "subcortical maternal complex" that runs early development). Variants in these genes can cause oocyte arrest, embryo arrest, or recurrent loss even when chromosomes look normal.
Why the egg's genes matter before the embryo's do
A newly fertilized egg does not start by reading the embryo's own genome. For the first days it runs on a pre-packed kit of proteins and RNA, deposited in the egg while it matured. Only after a few divisions does the embryo make the handoff to its own DNA — a step called embryonic genome activation. If the pre-packed kit is faulty, development can fail before that handoff ever happens (Sang, Ray & Wang, Science, 2023).
That is the defining feature of a maternal-effect gene: the mother's genotype, acting through the egg, shapes the early embryo regardless of the embryo's own chromosomes. It also explains the recurring theme in this whole group — a pregnancy or embryo can be chromosomally normal and still unable to develop.
The subcortical maternal complex
Several of these genes encode parts of a single machine inside the egg: the subcortical maternal complex (SCMC), which manages maternal RNA, mitochondria, and the genome-activation handoff. When a core part is missing, the whole machine underperforms — which is why variants in different SCMC genes can produce overlapping pictures of early embryonic arrest (SCMC and early embryonic arrest review, 2022).
| Gene | What it helps do | Typical pattern when altered |
|---|---|---|
| TUBB8 | Builds the egg's meiotic spindle for division | Oocyte maturation arrest, fertilization failure, early arrest |
| NLRP7 | Regulates early development and imprinting | Recurrent molar pregnancy, recurrent loss |
| PADI6 | SCMC component; supports genome activation | Early embryonic arrest (cleavage stage) |
| NLRP5 | Core SCMC protein (MATER) | Early embryonic arrest, imprinting disturbance |
| TLE6 | Core SCMC protein | Fertilization failure, early embryonic arrest |
| KHDC3L | SCMC-associated; imprinting | Recurrent molar pregnancy (NLRP7-negative) |
| OOEP | Core SCMC protein (FLOPED) | Early embryonic arrest |
A few related genes act at the same early stage without being part of the SCMC — for example WEE2, tied to fertilization failure, and PATL2, tied to oocyte maturation arrest. The common thread is timing: all of them govern the window between a mature egg and a few-day-old embryo.
How these genes are inherited
Most maternal-effect gene conditions are autosomal recessive: the affected woman carries two altered copies, one from each parent, while the parents themselves are unaffected carriers. TUBB8 is the exception that proves the rule — it can be dominant or recessive, and a healthy father can pass on a variant that only causes trouble when expressed in his daughter's eggs. In practice, that mix is why screening often looks at both partners.
Why a karyotype and carrier screening miss this layer
A karyotype reads the large-scale structure and number of chromosomes; it is built to catch balanced rearrangements, not single-gene changes. Standard carrier screening checks whether you carry well-known recessive conditions like cystic fibrosis — conditions in a future child — not the genes that decide whether a pregnancy develops in the first place.
Maternal-effect genes fall between those two tools. The peer-reviewed Human Intolerome, which catalogs 934 genes associated with prenatal or neonatal viability, found only limited overlap with a standard carrier-screening list — evidence that these are genuinely different genetic landscapes (Human Intolerome, Genetics in Medicine, 2026).
What this does and does not mean for you
If you have had repeated, unexplained failure very early — eggs that will not mature, embryos that arrest, or recurrent loss with normal chromosomes — this is a layer worth asking about. A well-supported finding can name a mechanism, clarify inheritance for your family, and shape the next conversation. It cannot promise a cause will be found, and a finding is not a diagnosis or a guarantee about a future cycle.
Where Reticular fits
Reticular's parent-only reproductive screen covers TUBB8, NLRP7, PADI6 and other maternal-effect and embryo-viability genes, reviewing saliva from one or both intended parents with genetic counseling included. It is aimed squarely at this blind spot — the single-gene layer beyond chromosome count — and is not a replacement for carrier screening, karyotyping, or embryo testing. Individual deep-dives are linked throughout: TUBB8, NLRP7, and PADI6.
FAQ
Common questions
Maternal-effect genes are a key group, including TUBB8 (the egg's meiotic spindle), NLRP7 (recurrent molar pregnancy), and subcortical maternal complex genes PADI6, NLRP5, TLE6, KHDC3L and OOEP (early embryonic arrest). Related genes like WEE2 and PATL2 act at the same early stage. These are rare causes and do not explain most pregnancy loss.
A maternal-effect gene is one where the mother's genotype, acting through the egg, controls how the early embryo develops — independent of the embryo's own chromosomes. The egg is pre-stocked with proteins and RNA that run the first days of development, so a faulty maternal-effect gene can cause failure before the embryo's own genome is even switched on.
Because many of them build the same machine inside the egg — the subcortical maternal complex, which runs the first days of development. Genes like NLRP5, TLE6, OOEP, PADI6 and KHDC3L each make a part of it, so a problem in any one of them can stall an embryo in a similar way.
A karyotype reads chromosome number and structure, not single genes, so it catches rearrangements but not maternal-effect variants. Standard carrier screening checks for well-known recessive conditions in a future child, not the genes that decide whether a pregnancy develops. Maternal-effect genes fall between the two, which is why a dedicated reproductive-gene screen is needed to see them.
Usually yes, and usually in an autosomal recessive pattern: the affected woman carries two altered copies while each parent is an unaffected carrier. TUBB8 is a partial exception because it can act dominantly and can be passed by a healthy father, which is one reason reproductive screening often examines both partners.
Which path is right for you?
Answer a few questions and we'll point you in the right direction.